The provision of information and informed decision-making on prenatal screening for Down syndrome: A questionnaire- and register-based survey in a non-selected population

Patient Education and Counseling

Volumn 87, Issue 3, 2012, Pages 351-359

  Schoonen, Marleen ^a   Wildschut, Hajo ^a   Essink Bot, Marie Louise ^b   Peters, Ingrid ^c   Steegers, Eric ^a   De Koning, Harry ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c Regional Centre for Prenatal Screening Southwest Netherlands   (Netherlands)

Author keywords

Down syndrome; Information provision; Informed decision making, Netherlands; Prenatal screening; Program Evaluation; Quality assurance

Indexed keywords

ACCESS TO INFORMATION; ADULT; ARTICLE; ATTITUDE TO HEALTH; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; HEALTH CARE SURVEY; HEALTH PROGRAM; HUMAN; INFORMATION DISSEMINATION; INFORMATION LITERACY; MEDICAL DECISION MAKING; MEDICAL PRACTICE; MIDWIFE; NETHERLANDS; PREGNANT WOMAN; PRENATAL SCREENING; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; QUALITY CONTROL; QUESTIONNAIRE; SCREENING TEST;

ADULT; ANALYSIS OF VARIANCE; DECISION MAKING; DOWN SYNDROME; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFORMED CONSENT; MIDWIFERY; MOTHERS; NETHERLANDS; PILOT PROJECTS; POPULATION SURVEILLANCE; PREGNANCY; PRENATAL CARE; PRENATAL DIAGNOSIS; QUALITY ASSURANCE, HEALTH CARE; QUESTIONNAIRES; REGISTRIES; SOCIOECONOMIC FACTORS;

EID: 84861226955     PISSN: 07383991     EISSN: 18735134     Source Type: Journal    
DOI: 10.1016/j.pec.2011.10.001     Document Type: Article

References (43)

1. Boyd P.A., Devigan C., Khoshnood B., Loane M., Garne E., Dolk H. EUROCAT Working Group. Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down's syndrome. Int J Obstet Gynaecol 2008, 115:689-696.
2. Health Council of the Netherlands. Population screening act. Prenatal screening on Down's syndrome and neural tube defects. Health Council of the Netherlands 2007/05; 2007.
3. Health Council of the Netherlands. Prenatal screening: Down's syndrome, neural tube defects, routine-ultrasonography 2001/11; 2001.
4. Health Council of the Netherlands. Prenatal screening (2); Down's syndrome, neural tube defects. Health Council of the Netherlands 2004/06; 2004.
5. Marteau T.M., Dormandy E., Michie S. A measure of informed choice. Health Expect 2001, 4:99-108.
6. Green J.M., Hewison J., Bekker H.L., Bryant L.D., Cuckle H.S. Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review. Health Technol Assess 2004, 1-109. 8:iii, ix-x,.
7. Dormandy E., Hooper R., Michie S., Marteau T.M. Informed choice to undergo prenatal screening: a comparison of two hospitals conducting testing either as part of a routine visit or requiring a separate visit. J Med Screen 2002, 9:109-114.
8. Dormandy E., Michie S., Hooper R., Marteau T.M. Informed choice in antenatal Down syndrome screening: a cluster-randomised trial of combined versus separate visit testing. Patient Educ Couns 2006, 61:56-64.
9. Gourounti K., Sandall J. Do pregnant women in Greece make informed choices about antenatal screening for Down's syndrome? A questionnaire survey. Midwifery 2008, 24:153-162.
10. Jaques A., Sheffield L., Halliday J. Informed choice in women attending private clinics to undergo first trimester screening for Down syndrome. Prenat Diagn 2005, 25:656-664.
11. van den Berg M., Timmermans D.R., ten Kate L.P., van Vugt J.M., van der Wal G. Informed decision making in the context of prenatal screening. Patient Educ Couns 2006, 63:110-117.
12. van den Berg M., Timmermans D.R., Ten Kate L.P., van Vugt J.M., van der Wal G. Are pregnant women making informed choices about prenatal screening?. Genet Med 2005, 7:332-338.
13. Fransen M.P., Essink-Bot M.L., Vogel I., Mackenbach J.P., Steegers E.A., Wildschut H.I. Ethnic differences in informed decision-making about prenatal screening for Down's syndrome. J Epidemiol Community Health 2010, 64:262-268.
14. Statistics Netherlands Gebieden in Nederland; 2007. [accessed on 14.05.10]. http://statline.cbs.nl/StatWeb/publication/%3FDM=SLNL%26PA=71377NED%26D1=2,48%26D2=a%26HDR=T%26STB=G1%26VW=T.
15. The Netherlands Perinatal Registry (PRN-foundation). Perinatal Care in the Netherlands; 2006, p. 94, Table 9.1.1 [accessed on 26.09.11]. http://www.perinatreg.nl/uploads/150/114/Jaarboek_Perinatale_Zorg_2006.pdf.
16. Schoonen HMHJD, van Agt H.M.E., Essink-Bot M.L., Wildschut H.I., Steegers E.A.P., de Koning H.J. Informed decision-making in prenatal screening for Down's syndrome: What knowledge is relevant. Patient Educ Couns 2011, 265-270.
17. Royal College of Obstetricians and Gynaecologists Report of the working party on biochemical markers and the detection of Down's syndrome 1993, RCOG Press.
18. Wald N. Information leaflets in medical screening. J Med Screen 2006, 13:109.
19. Michie S., Dormandy E., Marteau T.M. The multi-dimensional measure of informed choice: a validation study. Patient Educ Couns 2002, 48:87-91.
20. Dormandy E., Tsui E.Y., Marteau T.M. Development of a measure of informed choice suitable for use in low literacy populations. Patient Educ Couns 2007, 66:278-295.
21. The Netherlands Perinatal Registry (PRN Foundation) (Stichting Perinatale Registratie) [in Dutch]. The Netherlands Perinatal Registry; 2011. [accessed on 26.09.11]. http://www.perinatreg.nl/home_english.
22. Stronks K., Kulu-Glasgow I., Agyemang C. The utility of 'country of birth' for the classification of ethnic groups in health research: the Dutch experience. Ethn Health 2009, 14:1-14.
23. Statistics Netherlands Beroepsbevolking; behaalde onderwijs naar herkomst geslacht en leeftijd; 2009. [accessed on 29.04.10]. http://statline.cbs.nl/StatWeb/publication/%3FDM=SLNL%26PA=71822NED%26D1=0%26D2=l%26D3=1-3%26D4=0%26D5=a%26D6=0%26D7=l%26VW=T.
24. Statistics Netherlands Geboorte; herkomstgroepering en leeftijd moeder (op 31 december) 2009. [accessed on 29.04.10]. http://statline.cbs.nl/StatWeb/publication/%3FVW=T%26DM=SLNL%26PA=37884%26D1=0-2,8-9%26D2=0%26D3=0-2%26D4=l%26HD=100429-1135%26HDR=T%26STB=G2,G1,G3.
25. Statistics Netherlands Geboorte naar diverse kenmerken; 2009. [accessed on 29.04.10]. http://statline.cbs.nl/StatWeb/publication/%3FDM=SLNL%26PA=37422NED%26D1=40-44%26D2=l%26HDR=T%26STB=G1%26VW=T.
26. Eborall H.C., Griffin S.J., Prevost A.T., Kinmonth A.L., French D.P., Sutton S. Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial. Br Med J 2007, 335:486.
27. Nijs H.G., Essink-Bot M.L., DeKoning H.J., Kirkels W.J., Schroder F.H. Why do men refuse or attend population-based screening for prostate cancer?. J Public Health Med 2000, 22:312-316.
28. van den Bergh K.A., Essink-Bot M.L., van Klaveren R.J., de Koning H.J. Informed participation in a randomised controlled trial of computed tomography screening for lung cancer. Eur Respir J 2009, 34:711-720.
29. Bryant L.D., Green J.M., Hewison J. The role of attitudes towards the targets of behaviour in predicting and informing prenatal testing choices. Psychol Health 2009, 1-20.
30. Gekas J., Gondry J., Mazur S., Cesbron P., Thepot F. Informed consent to serum screening for Down syndrome: are women given adequate information?. Prenat Diagn 1999, 19:1-7.
31. Al-Jader L.N., Parry-Langdon N., Smith R.J. Survey of attitudes of pregnant women towards Down syndrome screening. Prenat Diagn 2000, 20:23-29.
32. Seror V., Ville Y. Prenatal screening for Down syndrome: women's involvement in decision-making and their attitudes to screening. Prenat Diagn 2009, 29:120-128.
33. Roelofsen E.E., Kamerbeek L.I., Tymstra T.J., Beekhuis J.R., Mantingh A. Women's opinions on the offer and use of maternal serum screening. Prenat Diagn 1993, 13:741-747.
34. van den Berg M., Timmermans D.R.M., ten Kate L.P., van Vugt J.M.G., van der Wal G. Informed decision making concerning prenatal screening. Patient Educ Couns 2006, 110-117.
35. Briss P., Rimer B., Reilley B., Coates R.C., Lee N.C., Mullen P., et al. Task force on community preventive services. Promoting informed decisions about cancer screening in communities and healthcare systems. Am J Prev Med 2004, 26:67-80.
36. Hewitson P., Austoker J. Part 2: patient information, informed decision-making and the psycho-social impact of prostate-specific antigen testing. Br J Urol Int 2005, 95(Suppl. 3):16-32.
37. Chilaka V.N., Konje J.C., Stewart C.R., Narayan H., Taylor D.J. Knowledge of Down syndrome in pregnant women from different ethnic groups. Prenat Diagn 2001, 21:159-164.
38. Gottfredsdottir H., Bjornsdottir K., Sandall J. How do prospective parents who decline prenatal screening account for their decision? A qualitative study. Soc Sci Med 2009, 69:274-277.
39. Spencer K., Spencer C.E., Power M., Moakes A., Nicolaides K.H. One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester. Int J Obstet Gynaecol 2000, 107:1271-1275.
40. Salonen R., Turpeinen U., Kurki L., Lappalainen M., Ammala P., Hiilesmaa V., et al. Maternal serum screening for Down's syndrome on population basis. Acta Obstet Gynecol Scand 1997, 76:817-821.
41. Gidiri M., McFarlane J., Holding S., Lindow S. Maternal serum screening for Down syndrome: are women's perceptions changing?. Int J Obstet Gynaecol 2007, 114:458-461.
42. Fracheboud J, van Agt HME, de Koning HJ. Landelijke inventarisatie van verrichtingen in het kader van de prenatale screening op Downsyndroom en het Structureel Echoscopisch Onderzoek-o.b.v. beschikbare data; 2008-2010.
43. Ekelund C.K., Jorgensen F.S., Petersen O.B., Sundberg K., Tabor A. Impact of a new national screening policy for Down's syndrome in Denmark: population based cohort study. Br Med J 2008, 337:a2547. Danish Fetal Medicine Research Group.